HG/T 6340-2024
GB/T 35500-2017
3,3,3,-Trifluoropropylmethyldimethoxysilane
GB/T 27715-2011
3-methylpyridine for industrial use
T/CIESC 46-2023
GA/T 1932-2021
Forensic sciences—Examination methods for BZP, mCPP and TFMPP in suspected drugs—GC and GC-MS
GA/T 1787-2021
Forensic sciences—Examination methods for BZP,mCPP and TFMPP in suspected drugs—LC and LC-MS
T/FSI 079-2022
32016R0486
HG/T 5687-2020
1,3,3-Trimethy-2-methyleneindoline
32013R0251
GB/T 43094-2023
Trans-1-chloro-3,3,3-trifluoropropene[HCFO-1233zd(E)] for industrial use
QB/T 4817-2015
Fragrance-3,3-dimethyl-5-(2,2,3-trimethyl-3cyclopenten-1-yl)-4-penten-2-ol
DB42/T 1720-2021
T/QGCML 748-2023
HG/T 5687\uff5e5688-2020
SN/T 5611-2024
HG/T 6315-2024
T/FSI 132-2023
32016R0001
Commission Regulation (EU) 2016/1 of 3 December 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, boscalid, cyazofamid, cyromazine, dazomet, dithiocarbamates, fluazifop-P, mepanipyrim, metrafenone, picloram, propamocarb, pyridaben, pyriofenone, sulfoxaflor, tebuconazole, tebufenpyrad and thiram in or on certain products (Text with EEA rel
GB 1886.99-2015